← Back to Patent Explorer
US5756291A Expired / Lapsed US ⏱️ 0.0 years remaining

Aptamers specific for biomolecules and methods of making

Assignee: Gilead Sciences Inc
•
Filing: 1995-06-07
•
Granted: 1998-05-26
•
Expires: 2015-06-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for identifying oligomer sequences, optionally comprising modified base, which specifically bind target molecules such as serum proteins, kinins, eicosanoids and extracellular proteins is described. The method is used to generate aptamers that bind to serum Factor X, PDGF, FGF, ICAM, VCAM, E-selectin, thrombin, bradykinin, PGF2 and cell surface molecules. The technique involves complexation of the target molecule with a mixture of oligonucleotides containing random sequences and sequences which serve as primer for PCR under conditions wherein a complex is formed with the specifically binding sequences, but not with the other members of the oligonucleotide mixture. The complex is then separated from uncomplexed oligonucleotides and the complexed members of the oligonucleotide mixture are recovered from the separated complex using the polymerase chain reaction. The recovered oligonucleotides may be sequenced, and successive rounds of selection using complexation, separation, amplification and recovery can be employed. The oligonucleotides can be used for therapeutic and diagnostic purposes and for generating secondary aptamers.

Inventors

  • 👤 Linda Griffin
  • 👤 Glenn Albrecht
  • 👤 John Latham
  • 👤 Lawrence Leung
  • 👤 Eric Vermaas
  • 👤 John J. Toole

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 15:33
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/14; C12N9/48; C12N9/50; C12N9/64; C12N9/6421; C12N9/6424; C12N9/6429; C12Q; C12Q1/00; C12Q1/68; C12Q1/6811; C12Y; C12Y304/00; C12Y304/21; C12Y304/21005

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 73 words
A method to detect the presence or absence of thrombin, which method comprises: a) contacting a sample suspected of containing thrombin with a single-stranded DNA aptamer coupled to a label under conditions wherein a complex between thrombin and the aptamer is formed; and b) detecting the presence or absence of said complex indicating the presence or absence of thrombin; wherein said aptamer comprises the sequence: ##STR17## wherein N is A, T or G.
Claim 2
Independent Claim 73 words
A method to detect the presence or absence of thrombin, which method comprises: a) contacting a sample suspected of containing thrombin with a single-stranded DNA aptamer coupled to a label under conditions wherein a complex between thrombin and the aptamer is formed; and b) detecting the presence or absence of said complex indicating the presence or absence of thrombin; wherein said aptamer comprises the sequence: ##STR17## wherein N is A, T or G.
Claim 3
Dependent Claim 9 words
The method of claim 1 wherein N is T.
Claim 4
Dependent Claim 28 words
The method of claim 1 wherein said aptamer comprises the sequence: ##STR18## wherein: N is A, T, or G; and Z is an integer from 2 to 5.
Claim 5
Dependent Claim 9 words
The method of claim 3 wherein Z is 3.
Claim 6
Dependent Claim 12 words
The method of claim 4 wherein said aptamer comprises the sequence: ##STR19##
Claim 7
Dependent Claim 13 words
The method of claim 5 wherein N is T (SEQ ID NO: 29).
Claim 8
Independent Claim 66 words
A method to purify thrombin, which method comprises: a) contacting a sample containing thrombin with a single-stranded DNA aptamer coupled to solid support under conditions wherein thrombin is bound to the aptamer coupled to solid support; b) washing unbound components of the sample; and c) recovering purified thrombin from said solid support; wherein said aptamer comprises the sequence: ##STR20## wherein N is A, T or G.
Claim 9
Independent Claim 66 words
A method to purify thrombin, which method comprises: a) contacting a sample containing thrombin with a single-stranded DNA aptamer coupled to solid support under conditions wherein thrombin is bound to the aptamer coupled to solid support; b) washing unbound components of the sample; and c) recovering purified thrombin from said solid support; wherein said aptamer comprises the sequence: ##STR20## wherein N is A, T or G.
Claim 10
Dependent Claim 9 words
The method of claim 7 wherein N is T.
Claim 11
Dependent Claim 28 words
The method of claim 7 wherein said aptamer comprises the sequence: ##STR21## wherein: N is A, T, or G; and Z is an integer from 2 to 5.
Claim 12
Dependent Claim 9 words
The method of claim 9 wherein Z is 3.
Claim 13
Dependent Claim 12 words
The method of claim 10 wherein said aptamer comprises the sequence: ##STR22##
Claim 14
Dependent Claim 13 words
The method of claim 11 wherein N is T (SEQ ID NO: 29).

References Cited (Backward Citations)

US4748156A Cited
WO1991002750A1 Cited
WO1991019813A1 Cited
US5270163A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2001-05-25 2001-11-24 2002-05-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2005-05-25 2005-11-24 2006-05-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2009-05-25 2009-11-24 2010-05-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag